Quotient Limited Announces Closing of Underwritten Offering of Ordinary Shares
03 août 2016 16h05 HE
|
Quotient Limited
JERSEY, Channel Islands, Aug. 03, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the closing of its underwritten public offering...
Quotient Limited to Report First Quarter Fiscal 2017 Financial Results and Host Conference Call
01 août 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, Aug. 01, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fiscal first...
Quotient Limited Announces Pricing of Underwritten Offering of Ordinary Shares
29 juil. 2016 09h15 HE
|
Quotient Limited
JERSEY, Channel Islands, July 29, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced the pricing of an underwritten public offering...
Quotient Limited Announces Proposed Underwritten Offering of Ordinary Shares
28 juil. 2016 16h10 HE
|
Quotient Limited
JERSEY, Channel Islands, July 28, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that it intends to commence an underwritten...
Quotient Limited Provides Update on the MosaiQ™ Development Plan and Reports Preliminary Fiscal First Quarter 2017 Revenues
11 juil. 2016 16h15 HE
|
Quotient Limited
Manufacturing system for MosaiQ™ consumables meeting design expectationsField trial instruments successfully pass rigorous internal evaluationMinor manufacturing facility modification recently...
Quotient Limited to Participate in Jefferies 2016 Global Healthcare Conference
31 mai 2016 08h30 HE
|
Quotient Limited
JERSEY, Channel Islands, May 31, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Limited Reports Continued Progress on the Development of MosaiQ™ and Fourth Quarter and Fiscal Year 2016 Financial Results
23 mai 2016 16h17 HE
|
Quotient Limited
Completed commissioning of initial manufacturing system for MosaiQTM consumablesFirst field trial instruments received for internal evaluation and validationGenerated positive study results for...
Quotient Limited to Report Fourth Quarter Fiscal 2016 Financial Results and Host Conference Call
11 mai 2016 08h02 HE
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that financial results for its fourth...
Quotient Limited to Participate in UBS Global Healthcare Conference
11 mai 2016 08h00 HE
|
Quotient Limited
JERSEY, Channel Islands, May 11, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that the company’s Chairman & CEO, Paul Cowan,...
Quotient Awarded Group Purchasing Contract with Premier, Inc. for Blood Bank Reagents
21 avr. 2016 08h22 HE
|
Quotient Limited
JERSEY, Channel Islands, April 21, 2016 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ:QTNT), a commercial-stage diagnostics company, today announced that its U.S. subsidiary, Quotient...